Adriana Cariddi

Biographie

Dr. Adriana Cariddi is a rheumatologist at the Immunology, Rheumatology, Allergy, and Rare Diseases Unit of IRCCS Ospedale San Raffaele, under the direction of Professor Lorenzo Dagna.

After graduating with honors in Medicine and Surgery from the University of Florence in 2019, Dr. Cariddi specialized with honors in Clinical Allergy and Immunology at Università Vita-Salute San Raffaele.

She completed pre- and post-graduate internships at the Immunology Department of Careggi Hospital in Florence.

Currently, Dr. Cariddi conducts outpatient activities at UNIRAR (including the biological drugs clinic and small vessel vasculitis clinic) and participates in night shifts in internal medicine departments.

Her primary clinical interests include rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, ANCA-associated vasculitis, Behçet's disease, and fibromyalgia.

Éducation

University of Florence
Degree in Medicine and Surgery - 2014

Vita e Salute San Raffaele University
Specialization in Allergology and Clinical Immunology - 2019

Avez-vous besoin d'un rendez-vous?

Contactez-nous et nous prendrons soin de vous.

Publications

Dernières publications

Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology.
Clin Exp Rheumatol. 2022 Oct 6.
Manfredi A et al.
Lire la suite
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study.
Arthritis Rheumatol.
Bettiol A et al.
Lire la suite
Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort'
Ann Rheum Dis. 2021 Oct.
Giuseppe A Ramirez et al.
Lire la suite
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
Eur Respir J. 2021 May 6
Bettiol A et al.
Lire la suite
Potential acceptance of COVID-19 vaccine in rheumatological patients: a monocentric comparative survey.
Ann Rheum Dis. 2021 Jun.
Campochiaro C et al.
Lire la suite
Living with fibromyalgia during the COVID-19 pandemic: mixed effects of prolonged lockdown on the well-being of patients.
Rheumatology (Oxford). 2021 Jan 5
Cavalli G et al.
Lire la suite
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study.
Ann Rheum Dis. 2020 Oct
Della Torre E et al.
Lire la suite
Safety and efficacy of rituximab biosimilar (CT-P10) in systemic sclerosis: an Italian multicentre study.
Rheumatology (Oxford). 2020 Dec 1
Campochiaro C et al.
Lire la suite
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors.
J Autoimmun. 2020 Mar.
Quartuccio L et al.
Lire la suite
Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience.
Rheumatology (Oxford). 2020 Jan 1
De Luca G et al.
Lire la suite
Eosinophils from Physiology to Disease: A Comprehensive Review.
Biomed Res Int. 2018 Jan 28
Ramirez GA et al.
Lire la suite

Avez-vous besoin d'un rendez-vous?

Contactez-nous et nous prendrons soin de vous.